APA (7th ed.) Citation

Bhattarai, M., Salih, M., Regmi, M., Al-Akchar, M., Deshpande, R., Niaz, Z., . . . Hegde, S. (2022). Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis. JAMA network open, 5(1), e2142078. https://doi.org/10.1001/jamanetworkopen.2021.42078

Chicago Style (17th ed.) Citation

Bhattarai, Mukul, Mohsin Salih, Manjari Regmi, Mohammad Al-Akchar, Radhika Deshpande, Zurain Niaz, Abhishek Kulkarni, Momin Siddique, and Shruti Hegde. "Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis." JAMA Network Open 5, no. 1 (2022): e2142078. https://doi.org/10.1001/jamanetworkopen.2021.42078.

MLA (9th ed.) Citation

Bhattarai, Mukul, et al. "Association of Sodium-Glucose Cotransporter 2 Inhibitors With Cardiovascular Outcomes in Patients With Type 2 Diabetes and Other Risk Factors for Cardiovascular Disease: A Meta-analysis." JAMA Network Open, vol. 5, no. 1, 2022, p. e2142078, https://doi.org/10.1001/jamanetworkopen.2021.42078.